Literature DB >> 19755789

Role of Rho/Rho-kinase and NO/cGMP signaling pathways in vascular function prior to atherosclerosis.

Mayumi Mori-Kawabe1, Hiromi Tsushima, Seigo Fujimoto, Toyohiro Tada, Jin-ichi Ito.   

Abstract

AIM: Atherosclerosis is a cardiovascular disease; however, there is little information on signal transduction for vascular function in the early stage of atherosclerosis. In this work, we investigated the role of Rho/Rho-kinase and nitrogen oxide (NO)/cyclic GMP (cGMP) signaling pathways in the aorta prior to atherosclerosis.
METHODS: Tension, the expression of RhoA protein, Rho-kinase activity and the cGMP level were measured using endothelium-intact or -denuded aorta prepared from apolipoprotein E-deficient (apoE-KO) and C57BL/6 wild-type (WT) mice at 2 months of age.
RESULTS: Phenylephrine (PE) induced less maximal contraction in the endothelium-denuded aorta from apoE-KO than from WT mice. A Rho-kinase inhibitor (Y-27632) reduced more effectively the contraction of apoE-KO than WT mice, but their RhoA proteins and Rho-kinase activities were not so different. Acetylcholine caused larger relaxation of the PE-stimulated, endothelium-intact aorta in apoE-KO due to endothelial NO release than WT mice. The basal cGMP level in the endothelium-intact aorta of apoE-KO mice was higher than that of WT.
CONCLUSIONS: Smooth muscle contraction via alpha(1)-adrenergic receptor shows higher dependency on Rho-kinase activity, suggesting down-regulation of the mechanism different from Rho/Rho kinase signaling in the aorta prior to atherosclerosis. Endothelium-dependent relaxation is also intensified through the NO/cGMP pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755789     DOI: 10.5551/jat.1875

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  8 in total

Review 1.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 2.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 3.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

4.  Regulation on RhoA in vascular smooth muscle cells under inflammatory stimulation proposes a novel mechanism mediating the multiple-beneficial action of acetylsalicylic acid.

Authors:  Dong-Bo Li; Guo-Jie Yang; Hong-Wei Xu; Zhi-Xuan Fu; Shan-Wei Wang; Shen-Jiang Hu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 5.  n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.

Authors:  Shusuke Yagi; Daiju Fukuda; Ken-Ichi Aihara; Masashi Akaike; Michio Shimabukuro; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2017-08-24       Impact factor: 4.928

Review 6.  Eicosanoids: Atherosclerosis and cardiometabolic health.

Authors:  Kimberly Piper; Mahdi Garelnabi
Journal:  J Clin Transl Endocrinol       Date:  2020-02-03

7.  Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse.

Authors:  Gregory E Bigford; Valerie C Bracchi-Ricard; Robert W Keane; Mark S Nash; John R Bethea
Journal:  ASN Neuro       Date:  2013-09-04       Impact factor: 4.146

8.  FSD-C10 Shows Therapeutic Effects in Suppressing oxidized low-density lipoprotein (ox-LDL)-Induced Human Brain Microvascular Endothelial Cells Apoptosis via Rho-Associated Coiled-Coil Kinase (ROCK)/Mitogen-Activated Protein Kinase (MAPK) Signaling.

Authors:  Xin Wang; Rongyan Mao; Weiwei Chen
Journal:  Med Sci Monit       Date:  2018-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.